Literature DB >> 22310950

Glomerular disease: perspectives on maintenance therapy in lupus nephritis.

James E Balow1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22310950      PMCID: PMC3874116          DOI: 10.1038/nrneph.2012.17

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Sequential therapies for proliferative lupus nephritis.

Authors:  Gabriel Contreras; Victoriano Pardo; Baudouin Leclercq; Oliver Lenz; Elaine Tozman; Patricia O'Nan; David Roth
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

2.  Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.

Authors:  Ellen M Ginzler; Mary Anne Dooley; Cynthia Aranow; Mimi Y Kim; Jill Buyon; Joan T Merrill; Michelle Petri; Gary S Gilkeson; Daniel J Wallace; Michael H Weisman; Gerald B Appel
Journal:  N Engl J Med       Date:  2005-11-24       Impact factor: 91.245

3.  Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide.

Authors:  J V Donadio; K E Holley; R H Ferguson; D M Ilstrup
Journal:  N Engl J Med       Date:  1978-11-23       Impact factor: 91.245

4.  The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.

Authors:  Phuong-Thu T Pham; Phuong-Chi T Pham
Journal:  Nephrol Dial Transplant       Date:  2011-12-29       Impact factor: 5.992

5.  Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial.

Authors:  Maria S Stoenoiu; Selda Aydin; Maria Tektonidou; Isabelle Ravelingien; Véronique le Guern; Christoph Fiehn; Philippe Remy; Michel Delahousse; Peter Petera; Thomas Quémeneur; Carlos Vasconcelos; David D'Cruz; Inge-Magrethe Gilboe; Michel Jadoul; Alexandre Karras; Geneviève Depresseux; Loïc Guillevin; Ricard Cervera; Jean-Pierre Cosyns; Frédéric A Houssiau
Journal:  Nephrol Dial Transplant       Date:  2011-11-22       Impact factor: 5.992

6.  Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.

Authors:  Mary Anne Dooley; David Jayne; Ellen M Ginzler; David Isenberg; Nancy J Olsen; David Wofsy; Frank Eitner; Gerald B Appel; Gabriel Contreras; Laura Lisk; Neil Solomons
Journal:  N Engl J Med       Date:  2011-11-17       Impact factor: 91.245

7.  Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.

Authors:  Thomas F Hiemstra; Michael Walsh; Alfred Mahr; Caroline O Savage; Kirsten de Groot; Lorraine Harper; Thomas Hauser; Irmgard Neumann; Vladimir Tesar; Karl-Martin Wissing; Christian Pagnoux; Wilhelm Schmitt; David R W Jayne
Journal:  JAMA       Date:  2010-11-08       Impact factor: 56.272

8.  Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

Authors:  D T Boumpas; H A Austin; E M Vaughn; J H Klippel; A D Steinberg; C H Yarboro; J E Balow
Journal:  Lancet       Date:  1992-09-26       Impact factor: 79.321

9.  Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.

Authors:  H A Austin; J H Klippel; J E Balow; N G le Riche; A D Steinberg; P H Plotz; J L Decker
Journal:  N Engl J Med       Date:  1986-03-06       Impact factor: 91.245

10.  Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.

Authors:  Giuseppe Remuzzi; Paolo Cravedi; Marco Costantini; Mariadomenica Lesti; Maria Ganeva; Giulia Gherardi; Bogdan Ene-Iordache; Eliana Gotti; Donato Donati; Maurizio Salvadori; Silvio Sandrini; Giuseppe Segoloni; Stefano Federico; Paolo Rigotti; Vito Sparacino; Piero Ruggenenti
Journal:  J Am Soc Nephrol       Date:  2007-04-25       Impact factor: 10.121

  10 in total
  1 in total

Review 1.  Effects of Integrated Traditional Chinese and Western Medicine for the Treatment of Lupus Nephritis: A Meta-Analysis of Randomized Trials.

Authors:  Mingli Heng; Jinli Tu; Yu Hao; Ye Zhao; Jinhui Tian; Huaien Bu; Hongwu Wang
Journal:  Evid Based Complement Alternat Med       Date:  2016-12-26       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.